title: Anemia during the predialysis period: A key to cardiac damage in renal failure.
authors.affiliation: Department of Nephrology, Tel Aviv Medical Center, Tel Aviv, Israel.
authors.forename: D
authors.initials: D
authors.lastname: Silverberg
authors.forename: M
authors.initials: M
authors.lastname: Blum
authors.forename: G
authors.initials: G
authors.lastname: Peer
authors.forename: A
authors.initials: A
authors.lastname: Iaina
mesh_terms: D000740:Anemia / Q000150:complications*; D004921:Erythropoietin / Q000627:therapeutic use; D006333:Heart Failure / Q000453:epidemiology* / Q000209:etiology; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000453:epidemiology* / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000503:physiopathology / Q000628:therapy; D009017:Morbidity; D011994:Recombinant Proteins; D017582:Renal Replacement Therapy; D012307:Risk Factors
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin